ALADDIN - evaluating change with technology

An award-winning, collaborative project led by the University of Southampton has been using technologies ranging from computer modelling to automated robots to investigate ways to improve the understanding of constantly changing scenarios.

The ALADDIN (Autonomous Learning Agents For Decentralised Data and Information Networks) research programme is a multi-million pound multidisciplinary strategic research partnership joint funded by BAE Systems and the Engineering and Physical Sciences Research Council and run in conjunction with researchers from the Universities of Bristol, Oxford, and Imperial College London.

Emergency situations place complex communications systems including multiple agencies, under severe strain. ALADDIN focuses on developing techniques and technology to overcome the challenges facing different agencies involved in an emergency response. For example, it can ensure a more effective response and improve the safety of men and women working in 'danger zones' or aid the safe evacuation of people from dangerous buildings after an earthquake.

The multi-agent toolbox developed by the ALADDIN researchers is applicable across a range of data and information applications, such as networked defence systems. BAE Systems is now integrating ALADDIN technology to improve a range of applications.

Related case studies

Reducing blood transfusions to lower patient risk, reduce costs and save lives

More than half a million people in the UK receive a blood transfusion each year and demand is increasing. Our ageing population, and a stringent donor selection process, mean the supply of blood is limited. 40% fewer new donors came forward last year compared with a decade ago. Recognising these challenges, researchers at the University of Edinburgh have shown the benefits of reducing the use of blood transfusions in intensive care and surgery.

Read more >

Developing the bowel cancer screening programme – Imperial College London

There are one million new diagnoses of colorectal cancer annually worldwide. It is the third most commonly diagnosed cancer and the second most frequent cause of cancer death in the UK – incurring costs to the NHS in excess of £1 billion annually.

Read more >